2[2]Ogihara T,Rakugi H,Ikegami H,et al.Enhancement of insulin sensitivity by troglitazone lowers blood pressure in diabetic hypertensives[J].Am J Hypertens,1995,8(3):316-320.
3[3]Yoshioka S,Nishino H,Shiraki T,et al.Antihypertensive effects of CS-045 treatment in obese Zucker rats[J].Metabolism,1993,42 (1):75-80.
4[4]Yoshimoto T,Naruse M,Nishikawa M,et al.Antihypertensive and vasculo-and renoprotective effects of pioglitazone in genetically obese diabetic rats[J].Am J Physiol,1997,272(6 Pt 1):E989-E996.
5[5]Buchanan TA,Meehan WP,Jeng YY,et al.Blood pressure lowering by pioglitazone.Evidence for a direct vascular effect[J].J Clin Invest,1995,96(1):354-360.
6[6]Nolan JJ,Ludvik B,Beerdsen P,et al.Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone[J].N Engl J Med,1994,331 (18):1188-1193.
7[7]Ledingham JM,Laverty R.Effects of glitazones on blood pressure and vascular structure in mesenteric resistance ar teries and basilar artery from genetically hypertensive rats[J].Clin Exp Pharmacol Physiol,2005,32(11):919,925.
8[8]Barroso I,Gurnell M,Crowley VE,et al.Dominant negative mutations in human PPARgamma associated with severe insulin resistance,diabetes mellitus and hypertension[J].Nature,1999,402(6764):880-883.
9[9]Savage DB,Tan GD,Acerini CL,et al.Human metabolic syndrome resulting from dominant negative mutations in the nuclear receptor peroxisome proliferator-activated receptor gamma[J].Diabetes,2003,52(4):910-917.
10[10]Walker AB,Chattington PD,Buckingham RE,et al.The thiazolidinedione rosiglitazone (BRL-49653) lowers blood pressure and protects against impairment of endothelial function in Zucker fatty rats[J].Diabetes,1999,48(7):1448-1453.
9SUTTON SJM,RENDELL M,PANDONA P,et al.A comparison of the effects of rosiglitazone and glyburide on cardiovascular function and glycemic control in patients with type 2 diabetes[J].Diabetes Care,2002,25(11):2058-2064.
10WINLSON PW.Diabetes mellitus and coronary heart disease[J].Am J Kidney Dis,1998,32(18):89-100.
